We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-3.39%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$2.6B
AUM Growth
+$272M
Cap. Flow
+$580M
Cap. Flow %
22.28%
Top 10 Hldgs %
59.11%
Holding
341
New
89
Increased
83
Reduced
62
Closed
85

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$32.4M
2
AZN icon
AstraZeneca
AZN
+$11.6M
3
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$10.4M
4
QRHC icon
Quest Resource Holding
QRHC
+$8.96M
5
MBOT icon
Microbot Medical
MBOT
+$7.86M

Top Sells

Rank Stock Value
1
WY icon
Weyerhaeuser
WY
+$64.6M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$53.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$16.1M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$13.3M
5
OPK icon
Opko Health
OPK
+$10.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.32%
2 Healthcare 6.56%
3 Energy 0.47%
4 Consumer Discretionary 0.36%
5 Industrials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OPK icon
276
Opko Health
OPK
$1.16B
– –
-1,193,955
Closed -$10.5M
OUT icon
277
Outfront Media
OUT
$5.01B
– –
-46,941
Closed -$1.15M
OUT icon
278
PUT
Outfront Media
OUT
$5.01B
– –
-2,004
Closed -$9.32M
PARA
279
DELISTED
Paramount Global Class B
PARA
– –
-48,100
Closed -$2.99M
PRTA icon
280
Prothena Corp
PRTA
$431M
– –
-9,800
Closed -$221K
PRTA icon
281
PUT
Prothena Corp
PRTA
$431M
– –
-100
Closed -$226K
REGN icon
282
Regeneron Pharmaceuticals
REGN
$79.9B
– –
-48,177
Closed -$16.1M
REGN icon
283
PUT
Regeneron Pharmaceuticals
REGN
$79.9B
– –
-1,913
Closed -$54M
TCRT icon
284
CALL
Alaunos Therapeutics
TCRT
$3.73M
– –
-4
Closed -$269K
TENX icon
285
CALL
Tenax Therapeutics
TENX
$68.5M
– –
0
– -$244K
TEVA icon
286
Teva Pharmaceuticals
TEVA
$45.1B
– –
-1,013,302
Closed -$53.7M
TLPH icon
287
Talphera
TLPH
$62.8M
– –
-5,145
Closed -$1.05M
TLPH icon
288
PUT
Talphera
TLPH
$62.8M
– –
-127
Closed -$2.61M
TPH
289
DELISTED
Tri Pointe Homes
TPH
– –
-18,438
Closed -$290K
TPH
290
PUT
DELISTED
Tri Pointe Homes
TPH
– –
-7,886
Closed -$12.4M
TPST icon
291
Tempest Therapeutics
TPST
$12.7M
– –
-62
Closed -$1.66M
UNH icon
292
CALL
UnitedHealth
UNH
$339B
– –
-450
Closed -$3.68M
UTHR icon
293
PUT
United Therapeutics
UTHR
$21.5B
– –
-119
Closed -$1.05M
WY icon
294
Weyerhaeuser
WY
$16B
– –
-1,950,977
Closed -$64.6M
WY icon
295
PUT
Weyerhaeuser
WY
$16B
– –
-13,500
Closed -$44.7M
XNTK icon
296
PUT
State Street SPDR NYSE Technology ETF
XNTK
$1.88B
– –
-212
Closed -$1.63M
CDMO
297
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-41,657
Closed -$7.03M
LUMO
298
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-110
Closed -$2.62M
LUMO
299
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-5,122
Closed -$1.22M
LUMO
300
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-18
Closed -$435K
10 11
12
13 14

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sabby Management held 341 positions worth $2.6B, up 12% from $2.33B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Sabby Management deployed $580M of net new capital in Q3 2014, opening 89 new positions and adding to 83 existing holdings. Its largest new stake was Acadia Healthcare: 663,324 shares worth $16.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 87% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was SALIX PHARMACEUTICALS LTD DEL, an estimated $6.87M trimmed.

  • Sabby Management's largest Q3 2014 buy was Acadia Healthcare: 663,324 shares worth $16.4M.
  • Sabby Management added most to AstraZeneca in Q3 2014, an estimated $11.6M increase.
  • Sabby Management's biggest Q3 2014 reduction was SALIX PHARMACEUTICALS LTD DEL, cutting an estimated $6.87M.
  • Sabby Management fully exited Weyerhaeuser in Q3 2014, selling an estimated $64.6M.
  • Sabby Management's ten largest holdings make up 59% of its $2.6B portfolio in Q3 2014.
  • Sabby Management opened 89 new positions and closed 85 in Q3 2014.
  • Sabby Management's portfolio value rose 12% quarter-over-quarter to $2.6B.

Based on Sabby Management's 13F filing for Q3 2014, filed 14 Nov 2014.